EPO and optic nerve disorder: Finally, erythropoietin has been studied in ischemic ocular neuropathies, such as NAION, due to its potential neuroprotective and anti-apoptotic effects that may mitigate ganglion-cell loss, in addition to its role in toxic optic neuropathies.